Liver Diseases  >>  pravastatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pravastatin / Generic mfg.
NCT01418729 / 2010-024421-21: Efficacy and Safety Study of Sorafenib Plus Pravastatin to Treat Advanced Hepatocarcinoma

Completed
2
216
Europe
Pravastatin
Hospital Donostia, INSTITUTO BIODONOSTIA
Advanced Hepatocarcinoma
12/15
06/17
PRODIGE 21 , NCT01357486: Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B Cirrhosis

Completed
2
160
Europe
sorafenib, Pravastatin, Sorafenib + Pravastatin, patients receiving best supportive care
University Hospital, Bordeaux, Federation Francophone de Cancerologie Digestive, UNICANCER
Hepatocellular Carcinoma, CHILD B
04/17
04/17

Download Options